caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1538236062

Rozalia Kovelman

General PracticeWest Hollywood, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Rozalia Kovelman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 38 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
K & T Diagnostic, Inc.
Independent Diagnostic Testing Facility (IDTF) · Van Nuys, CA
191288
Unilab Corporation
Clinical Laboratory · West Hills, CA
64110
Zorka Management Company Inc
Clinical Laboratory · Burbank, CA
61149
CENTRAL CITY COMMUNITY HEALTH CENTER59157
Syed Hossain
Internal Medicine · Compton, CA
55130
Alexander Gershman
Urology · Los Angeles, CA
4593
Vitae Diagnostics Incorporated
Clinical Laboratory · Torrance, CA
41104
Vlad Nusinovich
Internal Medicine · West Hollywood, CA
32144
SOUTHERN CALIFORNIA HEALTHCARE SYSTEM, INC2847
Ali Hadadz
General Practice · Marina Del Rey, CA
2672
Hanan Lobel
Internal Medicine · Van Nuys, CA
2673
Asya Kupisk
Psychiatry · Los Angeles, CA
2543
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
26
Beneficiaries
—
Total drug cost
$854
Distinct drugs
2
Brand share
0.0%
Top prescribed drugs
Halobetasol Propionate14 claims
Ketoconazole12 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.